AstraZeneca Vietnam's Hanoi office receives LEED Gold certificate

Vinh Phú |

On August 21, AstraZeneca Vietnam was awarded LEED Gold certificate by the US Green Building Council (USGBC) for its new office in Hanoi, marking an important step forward in the company's sustainable development strategy and long-term commitment in Vietnam. In more than 30 years of operation in Vietnam, AstraZeneca has accompanied the health sector to bring advanced health care solutions to the community. AstraZeneca Vietnam is the first inventive pharmaceutical company in Vietnam to be awarded LEED Gold certificate.

AstraZeneca Vietnam's new office in Hanoi will be deployed from October 2024 to June 2025, applying global iWork design standards, ensuring maximum support for flexible, cooperative and creative working methods. Modern amenities such as fair seats, modern and comfortable private and shared working areas, and friendly resting spaces are scientifically arranged to improve the health, spirit and productivity of employees.

Mr. Atul Tandon, General Director, AstraZeneca Vietnam, shared: We are very proud that our Hanoi office has achieved USGBC's LEED Gold certification. This is a testament to AstraZeneca's commitment to environmental management and sustainable development in Vietnam. This milestone reflects our commitment to creating a healthier working space for employees and minimizing environmental impact, while supporting Vietnam's national goal of green development. We really hope that our staff will always be inspired to continue to promote innovation, creating a positive difference for the community we serve.

Vinh Phú
TIN LIÊN QUAN

AstraZeneca organizes a series of scientific seminars on hereditary cancer

|

In order to improve the quality of treatment and health care for cancer patients in Vietnam, especially patients with genetic factors, AstraZeneca Vietnam Co., Ltd. accompanies frontline medical facilities in training to carry out a series of scientific activities: Conference "Oncology" of Bach Mai Hospital on June 14, 2025; Scientific workshop with Ho Chi Minh City Oncology Hospital and Cho Ray Hospital on June 20, 2025; deploy intensive extracurricular training on genetic consultation within the framework of a memorandum of understanding on cooperation with Ho Chi Minh City University of Medicine and Pharmacy on June 21, 2025.

AstraZeneca supports raising awareness and preventing and screening for breast cancer

|

AstraZeneca Vietnam is supporting organizations and hospitals to carry out many projects to raise awareness and treatment of breast cancer in the community. These activities continue to affirm AstraZeneca Vietnam's efforts to contribute to raising awareness and improving the quality of treatment for breast cancer patients in Vietnam.

AstraZeneca organizes a series of scientific seminars on hereditary cancer

Vinh Phú |

In order to improve the quality of treatment and health care for cancer patients in Vietnam, especially patients with genetic factors, AstraZeneca Vietnam Co., Ltd. accompanies frontline medical facilities in training to carry out a series of scientific activities: Conference "Oncology" of Bach Mai Hospital on June 14, 2025; Scientific workshop with Ho Chi Minh City Oncology Hospital and Cho Ray Hospital on June 20, 2025; deploy intensive extracurricular training on genetic consultation within the framework of a memorandum of understanding on cooperation with Ho Chi Minh City University of Medicine and Pharmacy on June 21, 2025.

AstraZeneca supports raising awareness and preventing and screening for breast cancer

Vinh Phú |

AstraZeneca Vietnam is supporting organizations and hospitals to carry out many projects to raise awareness and treatment of breast cancer in the community. These activities continue to affirm AstraZeneca Vietnam's efforts to contribute to raising awareness and improving the quality of treatment for breast cancer patients in Vietnam.

Bệnh viện Ung Bướu và AstraZeneca hợp tác nâng cao chất lượng điều trị

Vinh Phú |

Nhằm cải thiện chất lượng điều trị và chăm sóc sức khỏe cho bệnh nhân ung thư tại Việt Nam, Bệnh viện Ung Bướu TPHCM và công ty TNHH AstraZeneca Việt Nam đã tiếp tục đồng hành với việc ký kết hợp tác giai đoạn 2024 - 2027. Theo thống kê của GLOBOCAN năm 2022, mỗi năm tại Việt Nam ước tính có 180.480 ca mắc mới và 120.184 ca tử vong do ung thư. Thực trạng này đòi hỏi việc đẩy mạnh công tác chẩn đoán và nâng cao chất lượng điều trị ung thư ngày càng cao.